In this work, we have used CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) technologies to study the biologocal functions of ITGB5, TIMP1, and TMEM176B in prostate cancer cells. Here, TMEM176B is linked to prostate cancer.